Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Sell
37
AKAM Quote, Financials, Valuation and Earnings
Last price:
$76.59
Seasonality move
:
-3%
Day range:
$75.17 - $77.10
52-week range:
$67.51 - $106.80
Dividend yield:
0%
P/E ratio:
25.96x
P/S ratio:
2.93x
P/B ratio:
2.46x
Volume:
2M
Avg. volume:
2.7M
1-year change:
-15.19%
Market cap:
$11.3B
Revenue:
$4B
EPS (TTM):
$2.97
AKAM Analysts' Consensus Rating
The 20 analysts providing 12-month price projections for Akamai Technologies shares anticipate an average target of $102.63, ranging from a low estimate of $72.00 to a high estimate of $136.32. This average target implies a growth of 33.13% compared to the current stock price of $77.09.
Consensus Price Target
$102.63
Highest Price Target
$136.32
Lowest Price Target
$72.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 14 | 12 | 12 |
| Hold | 6 | 8 | 8 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
AKAM Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 4
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
